Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (14)

1

Cetuximab and panitumumab : are they interchangeable?

enthalten in: The Lancet. Oncology | 2009

von Kim, R.

2

Breaking the impasse : time for decisive action?

enthalten in: The Lancet. Oncology | 2008

3

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer : a randomised, multicentre, phase II trial

enthalten in: The Lancet. Oncology | 2008

von Cascinu, S. | Berardi, R. | Labianca, R. | +14

CommentIn: Lancet Oncol. 2008 Jan;9(1):7-8. - PMID 18177814

4

Improving treatment of pancreatic cancer

enthalten in: The Lancet. Oncology | 2008

von Philip, P.

CommentOn: Lancet Oncol. 2008 Jan;9(1):39-44. - PMID 18077217

5

Cetuximab for metastatic colorectal cancer

enthalten in: The Lancet. Oncology | 2007

von Sharma, S.

6

Anti-EGFR monoclonal antibody-induced hypomagnesaemia

enthalten in: The Lancet. Oncology | 2007

von Fakih, M.

CommentOn: Lancet Oncol. 2007 May;8(5):387-94. - PMID 17466895

7

Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer : a prospective study

enthalten in: The Lancet. Oncology | 2007

von Tejpar, S. | Piessevaux, H. | Claes, K. | +4

CommentIn: Lancet Oncol. 2007 May;8(5):366-7. - PMID 17466890

8

Response of thymoma to cetuximab

enthalten in: The Lancet. Oncology | 2007

von Farina, G. | Garassino, M. | Gambacorta, M. | +3

9

Circulating VEGF predicts efficacy of cetuximab

enthalten in: The Lancet. Oncology | 2007

von Paolino, A.

10

Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK

enthalten in: The Lancet. Oncology | 2006

von Barnett, D. | Stevens, A. | Longson, C.